Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 17, Issue 3, 2001, Pages 249-260

  Chang, T M S ^a   Prakash, S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Artificial cells; Bioencapsulation; Cells; Enzyme; Genetically engineered cells; Microencapsulation; Nanoencapsulation

Indexed keywords

AMMONIA; ENZYME; MULTIENZYME COMPLEX; NANOCAPSULE; PHENYLALANINE AMMONIA LYASE; UREA; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; BACTERIUM; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; LESCH NYHAN SYNDROME; LIVER CELL; LIVER FAILURE; MALE; MICROENCAPSULATION; MICROORGANISM; NONHUMAN; PHENYLKETONURIA; RAT;

ANIMALS; BIOCHEMISTRY; BIOTECHNOLOGY; CELL MEMBRANE; COLLODION; ENZYMES; ESCHERICHIA COLI; GENETIC ENGINEERING; GENETIC TECHNIQUES; HEPATOCYTES; HYDROGEN-ION CONCENTRATION; MALE; NYLONS; PSEUDOMONAS; RATS; RATS, WISTAR;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0034965972     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:17:3:249     Document Type: Article

References (41)

1. Semipermeable microcapsules
2. Semipermeable aqueous microcapsules: I. Preparation and properties
3. Artificial cells with emphasis on bioencapsulation in biotechnology
4. Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes
5. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: Preparation and characterization
6. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice
7. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma
8. Preparation and characterization of xanthine oxidase immobilized by microencapsulation in artificial cells for the removal of hypoxanthine
9. Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan disease
10. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria
11. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model
12. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: A preliminary report
13. Artificial cells with regenerating multienzyme systems
14. +
15. Microencapsulated islets as bioartificial endocrine pancreas
16. Bioartificial liver: Implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats
17. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice
18. Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model
19. Hepatocytes immobilized by microencapsulation in artificial cells: Effects on hyperbilirubinemia in Gunn Rats
20. Encapsulated hepatocytes for controlling hyper-bilirubinemia in Gunn Rats
21. Kinetics of UDP-glucuronosyl-transferase in bilirubin conjugation by encapsulated hepatocytes for transplantation into Gunn rats
22. A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival
23. Preparation and in-vitro analysis of genetically engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal
24. Microencapsulated genetically engineered live E coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats
25. Predicting nephrology in the 21st century
26. Bowel as a kidney substitute in renal failure
27. Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: A preliminary report
28. Secretion of erythropoietin from microencapsulated rat kidney cells: Preliminary results
29. Effects of mass transfer and reaction kinetics on serum cholesterol depletion rates of free and immobilized Pseudomonas pictorum
30. Characterization of free and alginate-polylysine-alginate microencapsulated Erwinia herbicola for the conversion of ammonia, pyruvate and phenol into L-tyrosine and L-DOPA J
31. Lipid-polymer membrane artificial cells containing multienzyme systems,cofactors and substrates for the removal of ammonia and urea
32. Stabilization of enzyme by microencapsulation with a concentrated solution o or by crosslinking with glutaraldehyde
33. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules
34. Therapeutic uses of microencapsulated genetically engineered cells